GSK Probe Prompts U.K. To Boost Drug Oversight
The United Kingdom is reportedly set to bolster its laws governing the oversight of pharmaceutical companies in the wake of an investigation into GlaxoSmithKline Plc's alleged delay in disclosing evidence that...To view the full article, register now.
Already a subscriber? Click here to view full article